Motor end plate innervation loss in diabetes and the role of insulin
- PMID: 21487310
- DOI: 10.1097/NEN.0b013e318215669a
Motor end plate innervation loss in diabetes and the role of insulin
Abstract
Retraction of distal sensory axons is a prominent feature in diabetic peripheral neuropathy (DPN), a process amenable to insulin therapy. Nevertheless, diabetic patients and long-term diabetic mice develop motor deficits after longer durations of DPN, a process that may be related to insulin deficiency. To compare the efficacy of intranasal delivery of insulin (IN-I) and subcutaneous insulin (Subc-I) in preventing motor deficits in a long-term mouse model of DPN, IN-I or Subc-I, 0.87 IU daily or placebo was delivered in separate cohorts of diabetic and nondiabetic CD1 mice for 8 months. Radiolabeled detection was used to assess insulin delivery and biodistribution. Biweekly behavioral tests and monthly electrophysiological and multipoint quantitative studies assessed motor function deficits. Morphometric analysis of spinal cord, peripheral nerve, muscle innervation, and specific molecular markers were evaluated at and before the end point. Despite progressive distal axonal terminal loss, numbers and caliber of motor neurons were preserved. There were no differences in glycemia between IN-I and Subc-I-treated mice. Intranasal delivery of insulin and, to a lesser extent, Subc-I, protected against electrophysiological decline, loss of neuromuscular junctions, and loss of motor behavioral skills. Intranasal delivery of insulin was associated with greater preservation of the phosphatidylinositol 3-kinase signaling pathway involving Akt, cyclic AMP response element binding protein,and glycogen synthase kinase 3β but did not alter extracellular signal-regulated kinase, mitogen-activated protein kinase/extracellular signal-regulated kinase, or c-Jun amino-terminal kinase. Thus, direct delivery of insulin to the nervous system might prevent motor deficit in human type 1 diabetes by preservation of the phosphatidylinositol 3-kinase-Akt pathway rather than only affecting glycemic levels; the effects of insulin on other signaling pathways may, however, play additional roles.
Similar articles
-
Intranasal insulin ameliorates experimental diabetic neuropathy.Diabetes. 2009 Apr;58(4):934-45. doi: 10.2337/db08-1287. Epub 2009 Jan 9. Diabetes. 2009. Retraction in: Diabetes. 2014 May;63(5):1817. doi: 10.2337/db14-rt05a. PMID: 19136650 Free PMC article. Retracted.
-
Local insulin and the rapid regrowth of diabetic epidermal axons.Neurobiol Dis. 2011 Aug;43(2):414-21. doi: 10.1016/j.nbd.2011.04.012. Epub 2011 Apr 17. Neurobiol Dis. 2011. PMID: 21530660
-
Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.Brain. 2008 Dec;131(Pt 12):3311-34. doi: 10.1093/brain/awn288. Epub 2008 Nov 16. Brain. 2008. Retraction in: Brain. 2014 Jun;137(Pt 6):e283. doi: 10.1093/brain/awu127. PMID: 19015157 Retracted.
-
Mechanisms of diabetic neuron damage: Molecular pathways.Handb Clin Neurol. 2014;126:379-99. doi: 10.1016/B978-0-444-53480-4.00028-X. Handb Clin Neurol. 2014. PMID: 25410235 Review.
-
Novel pathogenic pathways in diabetic neuropathy.Trends Neurosci. 2013 Aug;36(8):439-49. doi: 10.1016/j.tins.2013.04.008. Epub 2013 May 29. Trends Neurosci. 2013. PMID: 23725712 Review.
Cited by
-
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus.J Diabetes Res. 2018 Oct 4;2018:9763507. doi: 10.1155/2018/9763507. eCollection 2018. J Diabetes Res. 2018. PMID: 30402503 Free PMC article.
-
Diabetes Mellitus-Related Dysfunction of the Motor System.Int J Mol Sci. 2020 Oct 11;21(20):7485. doi: 10.3390/ijms21207485. Int J Mol Sci. 2020. PMID: 33050583 Free PMC article. Review.
-
Insulin signaling controls neurotransmission via the 4eBP-dependent modification of the exocytotic machinery.Elife. 2016 Aug 15;5:e16807. doi: 10.7554/eLife.16807. Elife. 2016. PMID: 27525480 Free PMC article.
-
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview.Pharmaceutics. 2019 Mar 13;11(3):118. doi: 10.3390/pharmaceutics11030118. Pharmaceutics. 2019. PMID: 30871237 Free PMC article. Review.
-
Characterization of sensory and motor dysfunction and morphological alterations in late stages of type 2 diabetic mice.Front Endocrinol (Lausanne). 2024 Mar 11;15:1374689. doi: 10.3389/fendo.2024.1374689. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38532899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous